1. Home
  2. FORM vs CORT Comparison

FORM vs CORT Comparison

Compare FORM & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

N/A

Current Price

$106.48

Market Cap

9.0B

Sector

Technology

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$87.32

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FORM
CORT
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.7B
IPO Year
2002
2001

Fundamental Metrics

Financial Performance
Metric
FORM
CORT
Price
$106.48
$87.32
Analyst Decision
Buy
Buy
Analyst Count
10
5
Target Price
★ $152.22
$141.00
AVG Volume (30 Days)
★ 1.8M
770.3K
Earning Date
10-28-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.96
0.09
Revenue
N/A
★ $761,407,000.00
Revenue This Year
$31.70
$50.53
Revenue Next Year
$18.42
$46.23
P/E Ratio
★ $105.15
$970.17
Revenue Growth
N/A
★ 12.79
52 Week Low
$44.16
$28.66
52 Week High
$160.27
$126.38

Technical Indicators

Market Signals
Indicator
FORM
CORT
Relative Strength Index (RSI) 42.55 25.54
Support Level $100.56 $77.38
Resistance Level $157.08 $122.93
Average True Range (ATR) 6.63 5.88
MACD -3.20 -3.63
Stochastic Oscillator 27.26 8.45

Price Performance

Historical Comparison
FORM
CORT

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: